Antibioticos Parenterales Hospital Clinico
ABASTECIMIENTO DE ANTIBIOTICOS DE USO PARENTERAL PARA EL HOSPITAL CLÍNICO DE MAGALLANES "DR. LAUTARO NAVARRO AVARIA".
23 oferente(s) participaron en esta licitación. El detalle de quién compitió y con qué oferta está en el registro oficial de Mercado Público.
Ver oferentes en Mercado Público →| Código | Fecha | Proveedor | Monto |
|---|---|---|---|
| 5070-4340-SE13 | 20-12-2013 | Merck Sharp & Dohme (I.a) Llc,agencia en Chile | $2.290.179 |
| 5070-4339-SE13 | 20-12-2013 | Pfizer Chile S.A. | $2.001.580 |
| 5070-4289-SE13 | 12-12-2013 | Pfizer Chile S.A. | $162.435 |
| 5070-4261-SE13 | 11-12-2013 | Laboratorio Volta S.A. | $199.920 |
| 5070-4251-SE13 | 11-12-2013 | Juan Daniel Zapata Zapata | $110.670 |
| 5070-4239-SE13 | 11-12-2013 | Astrazeneca S.A. | $785.400 |
| 5070-4254-SE13 | 11-12-2013 | Laboratorio Chile S.A. | $3.026.055 |
| 5070-4167-SE13 | 05-12-2013 | Aventis Pharma Holding Gmbh | $523.600 |
| 5070-4168-SE13 | 05-12-2013 | Merck Sharp & Dohme (I.a) Llc,agencia en Chile | $2.267.724 |
| 5070-3910-SE13 | 25-11-2013 | Astrazeneca S.A. | $1.309.000 |
| 5070-3970-SE13 | 13-11-2013 | Aventis Pharma Holding Gmbh | $664.019 |
| 5070-3956-SE13 | 13-11-2013 | Laboratorio Volta S.A. | $142.800 |
| 5070-3962-SE13 | 13-11-2013 | Merck Sharp & Dohme (I.a) Llc,agencia en Chile | $1.383.089 |
| 5070-3981-SE13 | 11-11-2013 | Juan Daniel Zapata Zapata | $221.340 |
| 5070-3602-SE13 | 11-10-2013 | Astrazeneca S.A. | $785.400 |
| 5070-3591-SE13 | 09-10-2013 | Merck Sharp & Dohme (I.a) Llc,agencia en Chile | $907.089 |
| 5070-3582-SE13 | 08-10-2013 | Aventis Pharma Holding Gmbh | $428.400 |
| 5070-3251-SE13 | 07-09-2013 | Productos Farmoquimicos Roche Limitada | $2.096.399 |
| 5070-3246-SE13 | 05-09-2013 | Merck Sharp & Dohme (I.a) Llc,agencia en Chile | $907.089 |
| 5070-3242-SE13 | 05-09-2013 | Laboratorio Volta S.A. | $199.920 |
| 5070-2934-SE13 | 13-08-2013 | Laboratorio Volta S.A. | $285.600 |
| 5070-2855-SE13 | 13-08-2013 | Aventis Pharma Holding Gmbh | $314.160 |
| 5070-2835-SE13 | 12-08-2013 | Merck Sharp & Dohme (I.a) Llc,agencia en Chile | $1.360.634 |
| 5070-2830-SE13 | 12-08-2013 | Astrazeneca S.A. | $523.600 |
| 5070-2943-SE13 | 12-08-2013 | Pfizer Chile S.A. | $4.967.120 |
| 5070-2915-SE13 | 12-08-2013 | Astrazeneca S.A. | $838.712 |
| 5070-2784-SE13 | 02-08-2013 | Aventis Pharma Holding Gmbh | $314.160 |
| 5070-2772-SE13 | 01-08-2013 | Aventis Pharma Holding Gmbh | $418.880 |
| 5070-2776-SE13 | 01-08-2013 | Pfizer Chile S.A. | $1.170.603 |
| 5070-2599-SE13 | 18-07-2013 | Aventis Pharma Holding Gmbh | $418.880 |
| 5070-2472-SE13 | 08-07-2013 | Pfizer Chile S.A. | $5.236.417 |
| 5070-2481-SE13 | 08-07-2013 | Merck Sharp & Dohme (I.a) Llc,agencia en Chile | $3.219.724 |
| 5070-2486-SE13 | 08-07-2013 | Aventis Pharma Holding Gmbh | $314.160 |
| 5070-2433-SE13 | 05-07-2013 | Astrazeneca S.A. | $1.624.112 |
| 5070-2451-SE13 | 05-07-2013 | Laboratorio Volta S.A. | $571.200 |
| 5070-2452-SE13 | 05-07-2013 | Laboratorio Chile S.A. | $7.284.227 |
| 5070-2456-SE13 | 05-07-2013 | Laboratorio Sanderson S.A. | $5.908.231 |
| 5070-2167-SE13 | 12-06-2013 | Pfizer Chile S.A. | $2.284.205 |
| 5070-2133-SE13 | 12-06-2013 | Astrazeneca S.A. | $1.570.800 |
| 5070-2174-SE13 | 12-06-2013 | Aventis Pharma Holding Gmbh | $314.160 |
| 5070-2147-SE13 | 11-06-2013 | Merck Sharp & Dohme (I.a) Llc,agencia en Chile | $2.267.724 |
| 5070-2082-SE13 | 07-06-2013 | Aventis Pharma Holding Gmbh | $314.160 |
| 5070-2084-SE13 | 07-06-2013 | Merck Sharp & Dohme (I.a) Llc,agencia en Chile | $907.089 |
| 5070-1675-SE13 | 07-05-2013 | Astrazeneca S.A. | $523.600 |
| 5070-1669-SE13 | 07-05-2013 | Merck Sharp & Dohme (I.a) Llc,agencia en Chile | $1.814.179 |
| 5070-1674-SE13 | 07-05-2013 | Aventis Pharma Holding Gmbh | $314.160 |
| 5070-1578-SE13 | 06-05-2013 | Productos Farmoquimicos Roche Limitada | $8.423.891 |
| 5070-1536-SE13 | 03-05-2013 | Merck Sharp & Dohme (I.a) Llc,agencia en Chile | $907.089 |
| 5070-1459-SE13 | 23-04-2013 | Merck Sharp & Dohme (I.a) Llc,agencia en Chile | $907.089 |
| 5070-1284-SE13 | 05-04-2013 | Merck Sharp & Dohme (I.a) Llc,agencia en Chile | $2.410.524 |
| 5070-1275-SE13 | 05-04-2013 | Astrazeneca S.A. | $1.362.312 |
| 5070-1249-SE13 | 05-04-2013 | Aventis Pharma Holding Gmbh | $580.720 |
| 5070-1279-SE13 | 05-04-2013 | Laboratorio Volta S.A. | $171.360 |
| 5070-1228-SE13 | 04-04-2013 | Pfizer Chile S.A. | $5.365.532 |
| 5070-1063-SE13 | 26-03-2013 | Aventis Pharma Holding Gmbh | $314.160 |
| 5070-1026-SE13 | 22-03-2013 | Productos Farmoquimicos Roche Limitada | $91.928 |
| 5070-1035-SE13 | 22-03-2013 | Astrazeneca S.A. | $785.400 |
| 5070-1027-SE13 | 22-03-2013 | Pfizer Chile S.A. | $397.412 |
| 5070-1006-SE13 | 21-03-2013 | Astrazeneca S.A. | $523.600 |
| 5070-923-SE13 | 15-03-2013 | Astrazeneca S.A. | $916.300 |
| 5070-879-SE13 | 13-03-2013 | Aventis Pharma Holding Gmbh | $209.440 |
| 5070-771-SE13 | 07-03-2013 | Laboratorio Chile S.A. | $2.677.500 |
| 5070-767-SE13 | 06-03-2013 | Astrazeneca S.A. | $1.570.800 |
| 5070-704-SE13 | 27-02-2013 | Aventis Pharma Holding Gmbh | $209.440 |
| 5070-508-SE13 | 14-02-2013 | Laboratorio Green Medical Limitada. | $178.976 |
| 5070-494-SE13 | 14-02-2013 | Astrazeneca S.A. | $523.600 |
| 5070-525-SE13 | 14-02-2013 | Laboratorio Volta S.A. | $171.360 |
| 5070-531-SE13 | 14-02-2013 | Merck Sharp & Dohme (I.a) Llc,agencia en Chile | $3.393.868 |
| 5070-537-SE13 | 14-02-2013 | Productos Farmoquimicos Roche Limitada | $61.285 |
| 5070-443-SE13 | 07-02-2013 | Astrazeneca S.A. | $1.570.800 |
| 5070-298-SE13 | 24-01-2013 | Pfizer Chile S.A. | $160.650 |
| 5070-277-SE13 | 22-01-2013 | Pfizer Chile S.A. | $1.428.000 |
| 5070-181-SE13 | 14-01-2013 | Pfizer Chile S.A. | $107.100 |
| 5070-165-SE13 | 14-01-2013 | Pfizer Chile S.A. | $57.477 |
| 5070-137-SE13 | 14-01-2013 | Pfizer Chile S.A. | $1.498.210 |
| 5070-97-SE13 | 10-01-2013 | Pfizer Chile S.A. | $107.100 |
| 5070-80-SE13 | 08-01-2013 | Laboratorio Volta S.A. | $199.920 |
| 5070-23-SE13 | 04-01-2013 | Pfizer Chile S.A. | $107.100 |
| 5070-4130-SE12 | 31-12-2012 | Productos Farmoquimicos Roche Limitada | $61.285 |
| 5070-4064-SE12 | 27-12-2012 | Pfizer Chile S.A. | $1.428.000 |
| 5070-3951-SE12 | 06-12-2012 | Pfizer Chile S.A. | $7.232.546 |
| 5070-3547-SE12 | 05-11-2012 | Pfizer Chile S.A. | $476.000 |
| 5070-3137-SE12 | 01-10-2012 | Pfizer Chile S.A. | $397.412 |
Fuente original:ficha mercadopublico.cl
